Navigation Links
China Genetic Engineering Drug Industry Report, 2011-2012
Date:7/16/2012

h of monoclonal antibody, long-acting recombinant protein drugs and other generic drugs with high technical barriers. On April 26th, 2012, Walvax announced to invest in Shanghai Fengmao in next four years to develop and produce genetic engineering generic drugs including rituximab, bevacizumab, adalimumab, panitumumab, denosumab and long-acting EPO.

Table of Contents

Papermaking

Selected Charts

Classification of Biopharmaceutical ProductsClassification of Genetic Engineering DrugsSales of Amgen's Four Genetic Engineering Drugs, 2009-2011R&D Cost of Main Biopharmaceutical Enterprises in the World, 2009-2011Competition Pattern of Genetic Engineering Drugs in China, 2011Comparison between China, USA and Japan by Commercialization Schedule of Some Genetic Engineering Protein DrugsExpiration Date of Main Genetic Engineering Drug Patents in the WorldMonoclonal Antibody Drugs Approved for Marketing in China, As of 2012Sales of Monoclonal Antibody Drugs in China, 2008-2011Some Listed Companies Investing in Monoclonal Antibody Industry in China, 2009-2012Sales Volume and Value of EPO in China, 1999-2011Competition Pattern of EPO in China (by Sales Volume or Value), 2007-2011Market Size of rh-IFN in China, 2006-2011Market Share of Major rh-IFN Injection Enterprises in China by Sales, 2006-2008Market Capacity Forecast of rh-IFN for Hepatitis Therapy in ChinaComparison Between Long-acting IFN and Conventional IFNMarket Share of Major rh-GH Enterprises in China, 2006-2008Market Capacity Forecast of rh-GH for Short Stature Therapy in ChinaMarket Prices of Common Insulin Products in China, 2010-2011Lot Release Volume and Its Growth Rate of Coagulation Factor VIII in China, 2008-2011 Market Share of rhG-CSF Enterprises in China, 2010Major Monoclonal Antibody Product Line under Research of Shanghai Lansheng Guojian PharmaceuticalRevenue and Net Income of Shanghai CP Guojian Pharmaceutical, 2008-2010Monoclonal Antibody Product Series under Research of Shangh
'/>"/>

SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Diagnostic Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018
2. Ampio Advances NCE001 Cancer Drug into Preclinical Development Following Successful Recent Financing and the Granting of Patents in USA, Canada, Europe and China
3. China Botanic Attends 2012 Trade Fair
4. The 2nd Pharma Logistics China 2012 to be Held in Shanghai on 21-22 August
5. China Pharmaceuticals and Healthcare Report Q3 2012
6. China Botanics Siberian Ginseng Extract Recognized as Safe Medicine
7. Biosimilars in Emerging Economies - Advanced Recombinant Technology Platforms and Low Cost Manufacturing Put India and China at a Strategic Advantage in Biosimilar Production
8. Diabetes Care Devices in Emerging Countries (China, India, Brazil) to 2017 - Greater Awareness is Increasing Demand for Self-Monitoring of Blood Glucose (SMBG) in the Home Care Segment
9. China ENT Devices Market Outlook to 2018 - Diagnostic Devices, Hearing Aid Devices, Hearing Implants and Others
10. The Pharmaceutical Market: China
11. China Biologic Receives SFDA Manufacturing Approval Certificate for Human Coagulation Factor VIII
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... , Sept. 17, 2014 Isis ... that it has earned a $4 million milestone ... ) associated with the initiation of a Phase ... multi-drug resistant (MDR), gram-negative bacterial infections.  The Phase ... to evaluate the efficacy and safety of plazomicin ...
(Date:9/17/2014)... Sutro Biopharma, a biopharmaceutical company developing antibody ... of Merck KGaA, Darmstadt, Germany , ... United States and Canada ... develop antibody drug conjugates (ADCs). ADCs are composed of ... is thought to specifically target and deliver the cytotoxic ...
(Date:9/17/2014)... , Sept. 17, 2014  Fortune Oil and Gas, ... its name to Manzo Pharmaceuticals, Inc. with the symbol ... effect today, September 17, 2014. Also taking effect today ... The approval is a pivotal event in the company,s ... Manzo explained, "We could not proceed with the plan ...
Breaking Medicine Technology:Isis Pharmaceuticals Earns $4 Million from Achaogen for the Initiation of a Phase 3 Study of Plazomicin 2Isis Pharmaceuticals Earns $4 Million from Achaogen for the Initiation of a Phase 3 Study of Plazomicin 3Sutro Biopharma and Merck KGaA of Darmstadt, Germany, to Partner on Development of Antibody Drug Conjugates 2Sutro Biopharma and Merck KGaA of Darmstadt, Germany, to Partner on Development of Antibody Drug Conjugates 3Sutro Biopharma and Merck KGaA of Darmstadt, Germany, to Partner on Development of Antibody Drug Conjugates 4Fortune Oil and Gas, Inc. announces 1 for 10 reverse split along with a name change to Manzo Pharmaceuticals is now effective 2Fortune Oil and Gas, Inc. announces 1 for 10 reverse split along with a name change to Manzo Pharmaceuticals is now effective 3
(Date:9/17/2014)... for the very healthy. Astronauts are selected for ... psychological standards to prepare them for any unknown ... average people can now fly for enjoyment. The ... about what medical conditions or diseases should be ... most medical conditions have never been studied for ...
(Date:9/17/2014)... (PRWEB) September 17, 2014 Functional Fitness ... Ritchie and Dr. Cody Sipe that is helping middle-aged adults ... and longevity has caught the attention of Shane Michaels, prompting ... in their 50s, 60s, or even 70s what would be ... on a day-to-day basis, they would probably answer that the ...
(Date:9/17/2014)... -- Social networking sites can help people lose weight, ... are obese, sites like Twitter and Facebook can be ... as well as peers, researchers found. "One advantage ... it offers the potential to be much more cost ... traditional approaches," the study,s lead author, Dr. Hutan Ashrafian, ...
(Date:9/17/2014)... 2014 The Oliver Law Group P.C. ... caused by Non-Sterile Other-Sonic Ultrasound Transmission Gel to ... options for legal recourse. Other-Sonic ultrasound gel was recalled ... March 2012, after the product was linked to a ... Hospital in Royal Oak, Michigan . While victims of ...
(Date:9/17/2014)... (PRWEB) September 17, 2014 Catalent ... delivery technologies and development solutions for drugs, biologics ... of OptiPact™, an integrated service and technology offer ... and provided from the company’s 450,000 sq. ft. ... Catalent’s ability to integrate optimal formulation, development, analytical ...
Breaking Medicine News(10 mins):Health News:Space: The final frontier… open to the public 2Health News:Functional Fitness Solution: Review Exposes Dr. Dan Ritchie and Dr. Cody Sipe’s Guide to Everyday Fitness for Longevity 2Health News:Social Networking Sites Can Help Obese Lose Weight: Study 2Health News:Victims of Pseudomonas Infections Allegedly Caused by Other-Sonic Ultrasound Transmission Gel Face Statute of Limitations, Reports The Oliver Law Group P.C. 2Health News:Victims of Pseudomonas Infections Allegedly Caused by Other-Sonic Ultrasound Transmission Gel Face Statute of Limitations, Reports The Oliver Law Group P.C. 3Health News:Victims of Pseudomonas Infections Allegedly Caused by Other-Sonic Ultrasound Transmission Gel Face Statute of Limitations, Reports The Oliver Law Group P.C. 4Health News:New OptiPact™ Technology Introduced by Catalent 2
... ATLANTA, Aug. 11 MinuteClinic, the pioneer and largest provider ... a first-of-its kind rapid conjunctivitis (pink-eye) test at its 23 locations ... test is a pilot project conducted in partnership with Rapid Pathogen ... at a future date in its clinic locations in 25 states. ...
... PITTSBURGH, Aug. 11 Foundation Radiology ... headquartered in Pittsburgh, is pleased to announce its exclusive imaging ... , Uniontown Hospital, a 224-bed hospital, has ... of Fayette County and surrounding areas for over 100 years. ...
... , SOMERSET, N.J., Aug. 11 ... healthcare and administrative staffing services, will announce its third quarter financial results ... before the market opens. TeamStaff will host a conference call for ... Interested parties may participate in the call by dialing (877) ...
... , , , SAN ... CXM ) today reported its financial results for its second ... future outlook. , , (Logo: http://www.newscom.com/cgi-bin/prnh/20051018/CARDIUMLOGO ... since first quarter 2009 financial report and highlights included (1) ...
... , , NEW YORK, Aug. ... a contract by ValueOptions(R), a behavioral health care company headquartered ... services for ValueOptions(R) at risk Plans, which cover approximately 1.5 ... Medicaid members that have other healthcare coverage, and recover overpayments ...
... MIAMI, Aug. 11 ECHealthInsurance.com a Florida based health ... month to help Floridians. According to Vice President of Marketing ... August is the only month every year that is open ... seasonality spikes of Florida our summer is much slower as ...
Cached Medicine News:Health News:MinuteClinic Offers New Rapid Pink-Eye Test; Detects Viral Conjunctivitis Infections in Minutes 2Health News:MinuteClinic Offers New Rapid Pink-Eye Test; Detects Viral Conjunctivitis Infections in Minutes 3Health News:Foundation Radiology Group Signs Exclusive Contract With Uniontown Hospital 2Health News:TeamStaff, Inc. To Announce Third Quarter Results 2Health News:TeamStaff, Inc. To Announce Third Quarter Results 3Health News:Cardium Reports on Second Quarter 2009 Financial Results and Recent Developments 2Health News:Cardium Reports on Second Quarter 2009 Financial Results and Recent Developments 3Health News:Cardium Reports on Second Quarter 2009 Financial Results and Recent Developments 4Health News:Cardium Reports on Second Quarter 2009 Financial Results and Recent Developments 5Health News:Cardium Reports on Second Quarter 2009 Financial Results and Recent Developments 6Health News:Cardium Reports on Second Quarter 2009 Financial Results and Recent Developments 7Health News:Cardium Reports on Second Quarter 2009 Financial Results and Recent Developments 8Health News:Cardium Reports on Second Quarter 2009 Financial Results and Recent Developments 9Health News:Cardium Reports on Second Quarter 2009 Financial Results and Recent Developments 10Health News:Cardium Reports on Second Quarter 2009 Financial Results and Recent Developments 11Health News:Cardium Reports on Second Quarter 2009 Financial Results and Recent Developments 12Health News:Cardium Reports on Second Quarter 2009 Financial Results and Recent Developments 13Health News:ValueOptions(R) Awards Coordination of Benefits and Overpayment Services Contract to HMS 2Health News:Florida Health Insurance Brokerage to Donate Month of August to Help Residents of Florida 2
... androgen secreted into the blood. In males, ... of the testes; in females ca. 50% ... of androstenedione, ca. 25% from the ovary ... The Testosterone ELISA KIT is based on ...
Microalbumin EIA Lipid / Protein Quantification 024-IDC-12...
Vitamin B6 REA Vitamin Assays, Cardiovascular 001-RK-VB6...
Myoglobin EIA Lipid / Protein Quantification, Cardiovascular 024-IDC-13 Muscle Disease...
Medicine Products: